Trial Profile
A Randomized, Double-blind Study to Determine the Effect of GK Activator (2) on Efficacy (HbA1c), Safety, Tolerability and Pharmacokinetics in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs Piragliatin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Roche
- 18 Jun 2007 Status changed from in progress to completed.
- 15 Nov 2006 Status change
- 12 Jul 2006 New trial record.